Fact Corp/ US3030392001 /
2019-09-17 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0008USD | - | 13,500 Turnover: - |
-Bid Size: - | -Ask Size: - | 0.0008 | 0.0008 |
GlobeNewswire
3:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Per...
GlobeNewswire
3:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Goo...
GlobeNewswire
3:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire
2:16 AM
Imperial Drilling Intersects 257.5 Metres Grading 0.71% Copper and 0.39 g/t Gold at Mount Polley
GlobeNewswire
2:00 AM
Carbon Streaming Announces Landmark Azuero Reforestation Carbon Removal Project in Collaboration Wit...
GlobeNewswire
05-21
Shareholders of Perion Network Ltd. Should Contact Levi & Korsinsky Before June 17, 2024 to Discuss ...
GlobeNewswire
05-21
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Poten...
GlobeNewswire
05-21
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for G...
GlobeNewswire
05-20
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene...
GlobeNewswire
05-17
FinTech Studios® Launches Apollo PRO® and RegLens PRO® Market Intelligence and Regulatory Intelligen...
GlobeNewswire
05-16
MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early...
GlobeNewswire
05-16
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the...
GlobeNewswire
05-16
Odysight.ai Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-15
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
05-15
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
GlobeNewswire
05-13
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
GlobeNewswire
05-09
Odysight.ai Receives a Purchase Order from Tel Aviv University and the Israel Ministry of Defense fo...